Featured Research

from universities, journals, and other organizations

In First Human Trial, Insulin Shows Ability To Reduce Components That Inflame Vessel Walls

Date:
August 9, 2001
Source:
University At Buffalo
Summary:
Insulin, the hormone used to treat diabetes, also may have potential as a treatment for heart disease, a study conducted by endocrinologists at the University at Buffalo has shown.

BUFFALO, N.Y. - Insulin, the hormone used to treat diabetes, also may have potential as a treatment for heart disease, a study conducted by endocrinologists at the University at Buffalo has shown.

The research shows for the first time that insulin produces an anti-inflammatory effect by decreasing concentrations of certain pro-inflammatory components in the bloodstream and increasing concentrations of components that help prevent inflammation and damage to cells lining blood vessels walls.

The study appeared in the July issue of The Journal of Clinical Endocrinology and Metabolism.

"This is a brand new property of insulin," said Paresh Dandona, M.D., UB associate professor of medicine and director of Kaleida Health's Diabetes-Endocrinology Center of Western New York.

"It is the first study of insulin's anti-inflammatory effect in humans and the results are clear. Since atherosclerosis is the result of an inflammation of the vessel wall, we believe insulin will prove to be anti-atherosclerotic in the long run.

"At the very least, these results should indicate to physicians that they should not be reluctant to prescribe insulin when it is indicated for fear that it may increase the risk of heart attack. It appears insulin has just the opposite effect. It may reduce the risk of heart attack."

Dandona and colleagues, in earlier laboratory-based research, had shown that insulin helps vessels to dilate by increasing the release of nitric oxide, a known vasodilator, and increasing expression of nitric oxide synthase, the enzyme that makes nitric oxide.

They also had shown that troglitazone, a substance that makes cells more sensitive to insulin, has anti-inflammatory effects, and that insulin decreased the expression of a component called intracellular adhesion molecule-1 (ICAM-1), known to promote inflammation in the lining of the arteries that has been associated with an increased risk of coronary artery disease.

These results appeared to suggest that insulin may help protect against cardiovascular disease, rather than contributing to its development, as other researchers have assumed, Dandona noted.

Seeking to determine if insulin produced similar effects in humans, Dandona and colleagues infused insulin in a glucose solution into 10 obese nondiabetic volunteers (obese subjects show increased inflammation) and monitored levels of certain pro- and anti-inflammatory blood components.

Blood samples were taken before the infusion began and at two, four and six hours into the procedure. Researchers were particularly interested in concentrations of a component called nuclear factor kB (NFkB), which induces the production of pro-inflammatory cytokines, adhesion molecules and enzymes that generate cell-damaging free radicals.

They also measured a component that inhibits NFkB, called IkB, and certain other anti-inflammatory components, as well as concentrations of adhesion molecules and free radicals.

Results showed that insulin infusion caused a fall in NFkB and an increase in its inhibitor. These changes began at two hours and peaked at four hours. NFkB returned to normal at six hours, but IkB continued to increase, even at six hours.

"These changes are consistent with an acute anti-inflammatory effect of insulin," Dandona said, "and suggest that in the long term, a persistent effect of this kind would indicate a potential antiatherogenic action of this hormone."

Also participating in the research were Ahmed Aljada, Ph.D., UB research assistant professor of medicine; Priya Mohanty, UB clinical instructor of medicine, and Husam Ghanim, Wael Hamouda, Ezzat Assian and Shakeel Ahmad, doctoral students working with Dandona.

The William G. McGowan Charitable Fund supported the work.


Story Source:

The above story is based on materials provided by University At Buffalo. Note: Materials may be edited for content and length.


Cite This Page:

University At Buffalo. "In First Human Trial, Insulin Shows Ability To Reduce Components That Inflame Vessel Walls." ScienceDaily. ScienceDaily, 9 August 2001. <www.sciencedaily.com/releases/2001/08/010809071400.htm>.
University At Buffalo. (2001, August 9). In First Human Trial, Insulin Shows Ability To Reduce Components That Inflame Vessel Walls. ScienceDaily. Retrieved July 26, 2014 from www.sciencedaily.com/releases/2001/08/010809071400.htm
University At Buffalo. "In First Human Trial, Insulin Shows Ability To Reduce Components That Inflame Vessel Walls." ScienceDaily. www.sciencedaily.com/releases/2001/08/010809071400.htm (accessed July 26, 2014).

Share This




More Health & Medicine News

Saturday, July 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins